Manufacturing guide
Oral Strip MOQ, Cost and Lead Time
There is no responsible universal MOQ, unit cost or lead time for oral strips. Commercial terms depend on development status, formula, web and cutting efficiency, packaging, testing, material commitments and manufacturer capacity.
Short answer
There is no dependable market-wide MOQ, unit cost or lead time for oral strips. The useful answer is supplier- and brief-specific. A custom product that still needs formulation, methods, prototypes and printed unit-dose packaging will be quoted differently from a transferred formula using qualified materials and an available pack. Ask for the minimum, cost and schedule in separate layers so a low production-unit price does not hide development, testing, packaging or material commitments.
First identify which minimum you are discussing
“MOQ” can describe several different constraints. The largest one often controls the commercial order.
| Minimum | What it may refer to | Question to ask |
|---|---|---|
| Development minimum | Paid project, prototype rounds or sample units | What work and how many revisions are included? |
| Wet-batch minimum | Smallest practical mix or coating batch | How many usable strips does that produce after expected losses? |
| Converting minimum | Efficient web, cutting or pouching run | Is this measured in web length, strips or packed units? |
| Printed-packaging minimum | Pouches, reels, cartons or print cylinders | Must unused packaging be purchased or stored? |
| Raw-material minimum | Supplier pack size or custom active purchase | Who owns unused material and how is it stored? |
| Commercial-order minimum | Finished strips, pouches, cartons or order value | Which unit is contractually binding? |
These are practical procurement categories. A manufacturer may combine or describe them differently.
What usually drives oral-strip MOQ
Minimum quantity can be shaped by mixing and coating setup, practical wet-batch size, web utilization, drying and line speed, cutting yield, pouching setup, cleaning or changeover, test samples, printed-material commitments and the manufacturer’s production schedule. The binding constraint may come from the pack converter rather than the film line. Review the manufacturing process and packaging requirements before assuming the film run alone sets the order minimum.
A quote should state the assumed yield and the unit being purchased. “10,000” is ambiguous unless it says whether that means strips, sealed pouches, retail cartons, batches or a currency value. Never convert one supplier’s dated quote into an industry-wide benchmark.
Separate development cost from production cost
| Cost layer | Typical scope to clarify | Common omission |
|---|---|---|
| Feasibility | Technical review, sourcing and initial screening | Work stops if the concept is not feasible |
| Formulation and prototypes | Formula work, sample rounds and documented revisions | Additional iterations charged separately |
| Analytical work | Method selection, development, transfer or external laboratory work | Stability and specialist tests excluded |
| Materials | Active, excipients, qualification and minimum purchases | Unused inventory or premium grades |
| Film production | Mixing, forming, drying, yield and conversion | Scrap and startup losses |
| Packaging | Laminate, printing, pouching, cartons and setup | Tooling, plates, cylinders or unused stock |
| Release and stability | Batch release, retained samples and stability program | Market-specific or long-term work |
| Logistics | Freight, insurance, export documents, duties and delivery basis | Taxes and destination costs |
Compare quotes only after these scopes match. A lower per-strip figure can be more expensive overall if it excludes the work required to reach a saleable product.
CoManufacturing commercial and manufacturing reference points
These are CoManufacturing planning reference points from its current manufacturing context, not market-wide averages, binding quotations or promises from every supplier.
| Planning item | CoManufacturing reference point | Important conditions |
|---|---|---|
| Custom commercial oral dissolving film MOQ | Approximately 150,000 strips per SKU | Custom formula, packaging, testing, material commitments and manufacturing arrangement can change the applicable minimum |
| Existing or white-label program quantity | May be lower in certain programs | Depends on the existing formulation, packaging and manufacturing arrangement; do not apply this to custom development |
| Custom R&D and prototyping cycle | Approximately 2–4 weeks | Depends on formulation complexity, raw-material availability and the number of iterations |
| Commercial manufacturing after final approvals | Commonly planned at approximately 45–60 days | Begins after final formulation and artwork/packaging approval and remains subject to materials, packaging, testing and production scheduling |
These reference points should be re-confirmed for the actual brief and supplier. Internal development fees and per-strip pricing are deliberately not published; compare cost through scope and cost drivers instead.
How to build a realistic lead time
The 2–4 week R&D reference and 45–60 day commercial-manufacturing reference are separate planning windows, not a single guaranteed launch schedule. A responsible plan follows the dependencies:
- Product brief and feasibility review.
- Raw-material identification and sourcing.
- Formulation and prototype rounds.
- Analytical method and testing readiness.
- Packaging specification, artwork and material procurement.
- Pilot or scale-up confirmation.
- Release, stability commitments and regulatory work appropriate to the market.
- Commercial scheduling, production, packing and dispatch.
Some activities can overlap, but packaging should not be treated as final while strip dimensions or stability needs remain unstable. A manufacturer-specific timeline should identify its critical path, client approval points and assumptions about material availability.
Quote-ready brief
Before asking for price, provide:
- intended product and target market;
- active identity, grade and working dose;
- one-strip or multi-strip serving direction;
- current formulation and prototype status;
- target strip dimensions or the fact that they remain open;
- sensory and disintegration direction;
- proposed pouch and retail-pack architecture;
- required testing, documentation and stability scope;
- launch quantity, forecast and destination;
- target timing and which dates are genuinely fixed.
Mark unknowns. A supplier can quote a development phase around uncertainty, but should not disguise an undefined concept as a fixed commercial offer.
How to compare two quotes
Normalize each proposal before deciding.
| Comparison question | Why it changes the answer |
|---|---|
| Are both suppliers pricing the same product state? | Development and routine production have different economics. |
| Is quantity expressed in the same unit? | Strips, pouches and cartons are not interchangeable. |
| Is yield treated the same way? | Quoted batch size may not equal saleable output. |
| Is packaging included at the same specification? | Laminate, print and secondary pack can control MOQ and cost. |
| Are tests and stability included? | Excluded analytical work can materially change total cost and time. |
| Who owns formula, methods and unused materials? | Ownership affects transfer and future orders. |
| Are freight, tax and delivery terms comparable? | Ex-works and delivered costs answer different questions. |
Commercial warning signs
Pause when a supplier offers a fixed commercial price before understanding dose, formulation state and pack; quotes an MOQ without a unit; promises a timeline without material or approval assumptions; claims all development and testing are included without defining them; or refuses to explain ownership, yield and unused inventory. These signals do not prove the supplier is unsuitable, but they make the offer impossible to compare responsibly.
Common questions
Can I get an MOQ before the formula is finished?
You can get a supplier-specific planning assumption, but it should state that formula, yield, test and packaging decisions may change it.
Why can packaging set the MOQ?
Printed laminate or cartons may have purchase and setup requirements larger than the film run itself.
Is pilot quantity the commercial MOQ?
Not necessarily. Prototype, pilot and routine production runs answer different questions and have different setup economics.
What is the most useful first commercial number?
Often it is the fully scoped cost to reach a credible pilot or quote-ready specification—not an unsupported mass-production unit price.
Evidence and sources
Evidence guide: Published evidence — supported by the linked literature. · CoManufacturing experience — practical development observations, not universal specifications. · Supplier-specific — confirm with the supplier being evaluated. · Product-specific validation — prove with the actual formula, process, pack and market.
Published literature supports the process dependencies described here, but not universal commercial figures. MOQ, price, capacity and lead time are supplier-specific and must be confirmed by dated quotations.
- Oliveira et al., “Oral disintegration films: applications and production methods,” Journal of Food Science and Technology 60 (2023): 2539–2548. doi:10.1007/s13197-022-05589-9 · Full text
- Özakar and Özakar, “Current Overview of Oral Thin Films,” Turkish Journal of Pharmaceutical Sciences 18 (2021): 111–121. doi:10.4274/tjps.galenos.2020.76390 · Full text